혈역학 모니터링 기기 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2024-2032년)

The Global Hemodynamic Monitoring Devices Market was worth USD 1.4 billion in 2023, with an estimated CAGR of 6.7% from 2024 to 2032. These devices are crucial for assessing and tracking cardiovascular performance, specifically monitoring blood flow and pressure within the circulatory system. They provide real-time data on critical physiological parameters, such as cardiac output, blood pressure, oxygenation levels, and vascular resistance, enabling healthcare providers to evaluate heart function and fluid balance effectively. The increasing prevalence of cardiovascular conditions, including heart disease and hypertension, is a significant driver of market growth. Hemodynamic monitoring devices are indispensable for managing chronic and acute cardiovascular conditions, guiding treatment, and improving patient outcomes.

In terms of products, the hemodynamic monitoring device market is divided into disposables and monitors. The disposables segment was valued at USD 437.9 million in 2023. Single-use disposables are essential for minimizing the risk of cross-contamination and hospital-acquired infections (HAIs). In critical care settings, where patients often have compromised immune systems, sterile single-use items like catheters, pressure transducers, and electrodes are vital for preventing pathogen transmission. Based on system type, the hemodynamic monitoring devices market is divided into non-invasive, invasive, and minimally invasive segments.

The non-invasive segment dominated in 2023 with a revenue of USD 719.2 million, and it is expected to grow at a CAGR of 6.8% over the forecast period. There is a growing preference for minimally invasive or non-invasive healthcare options among healthcare providers and patients. Non-invasive hemodynamic monitoring devices are increasingly popular because of their ability to reduce complication risks, minimize patient discomfort, and shorten recovery times compared with traditional invasive monitoring systems. Additionally, technological advancements in sensor technology, wireless communication, and data processing have enhanced the accuracy and reliability of non-invasive hemodynamic monitoring devices.

North America hemodynamic monitoring devices market is forecast to reach USD 888.1 million by 2032. U.S. market held a revenue of USD 470.5 million in 2023, driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular conditions, and neurological disorders across the region, highlighting the critical need for advanced monitoring systems. Accurate and reliable hemodynamic monitoring is essential for effectively managing these conditions, given the high incidence rates.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of chronic diseases across the globe
    • 3.2.1.2 Technological advancements in hemodynamic monitoring devices
    • 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
    • 3.2.1.4 Growing preference for telehealth services
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of patient monitoring devices
    • 3.2.2.2 Stringent regulatory framework
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 U.S.
  • 3.4.2 Europe
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Disposables
• 5.3 Monitors

Chapter 6 Market Estimates and Forecast, By System Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Non-invasive
• 6.3 Invasive
• 6.4 Minimally invasive

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Homecare settings
• 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Baxter International
• 9.3 Canon Medical Systems Corporation
• 9.4 Deltex Medical Group
• 9.5 Edwards Lifesciences Corporation
• 9.6 GE HealthCare Technologies
• 9.7 Getinge
• 9.8 ICU Medical
• 9.9 Koninklijke Philips N.V.
• 9.10 Masimo Corporation
• 9.11 Nihon Kohden Corporation
• 9.12 OSYPKA MEDICAL
• 9.13 Siemens Healthineers